Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

NCT00782626 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Low-grade Glioma
Astrocytoma

Interventions

DRUG: everolimus

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]